ViiV Healthcare UK Ltd. v. Aurobindo Pharma Ltd.
1:14-cv-00868
Overview
Parties
Defendant
Aurobindo Pharma USA Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
ViiV Healthcare Co. Operating Company
Represented By
3 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
ViiV Healthcare UK Ltd. Operating Company
Represented By
3 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6294540
Carbocyclic nucleoside hemisulfate and its use in treating viral infections
|
Filed: 1998-05-14
Issued: 2001-09-25
|
Expired (Term Ended)
Expires: 2018-05-14
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
8
Dispositive
0
Granted
2
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings